2 A crystal structure of an extracellular fragment of human CD40 ligand

Structure
M KarpusasD Thomas

Abstract

The CD40 ligand (CD40L) is a member of the tumor necrosis factor (TNF) family of proteins and is transiently expressed on the surface of activated T cells. The binding of CD40L to CD40, which is expressed on the surface of B cells, provides a critical and unique pathway of cellular activation resulting in antibody isotype switching, regulation of apoptosis, and B cell proliferation and differentiation. Naturally occurring mutations of CD40L result in the clinical hyper-IgM syndrome, characterized by an inability to produce immunoglobulins of the IgG, IgA and IgE isotypes. We have determined the crystal structure of a soluble extracellular fragment of human CD40L to 2 A resolution and with an R factor of 21.8%. Although the molecule forms a trimer similar to that found for other members of the TNF family, such as TNF alpha and lymphotoxin-alpha, and exhibits a similar overall fold, there are considerable differences in several loops including those predicted to be involved in CD40 binding. The structure suggests that most of the hyper-IgM syndrome mutations affect the folding and stability of the molecule rather than the CD40-binding site directly. Despite the fact that the hyper-IgM syndrome mutations are dispersed in the prima...Continue Reading

References

Dec 1, 1992·European Journal of Immunology·D GrafR A Kroczek
Dec 1, 1992·The Journal of Experimental Medicine·M K SpriggsW C Fanslow
May 7, 1992·Nature·R J ArmitageC R Maliszewski
Jul 2, 1992·Nature·T Farrah, C A Smith
Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R J NoelleA Aruffo
Mar 16, 1989·Nature·E Y JonesN P Walker
Apr 28, 1968·Journal of Molecular Biology·B W Matthews
Nov 1, 1993·Protein Science : a Publication of the Protein Society·J BajorathA Aruffo
Jan 20, 1995·Science·T Clackson, J A Wells
May 1, 1995·Nature Medicine·J RubyI A Ramshaw
Aug 1, 1994·Immunity·J XuR A Flavell
Nov 1, 1994·The Journal of Experimental Medicine·B R RenshawC R Maliszewski
Feb 11, 1993·Nature·J P DiSantoG de Saint Basile
Jan 1, 1994·Protein Engineering·X Van OstadeW Fiers
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Sep 1, 1993·Current Biology : CB·J F Bazan
Jan 23, 1987·Science·A T BrüngerM Karplus

❮ Previous
Next ❯

Citations

Jun 26, 1999·European Journal of Immunology·P SchneiderH Wajant
Mar 1, 1996·Protein Science : a Publication of the Protein Society·J BajorathA Aruffo
May 30, 1998·Protein Science : a Publication of the Protein Society·J SinghD Thomas
Jan 1, 1996·International Journal of Clinical & Laboratory Research·H J Gruss
May 16, 2009·Cancer Immunology, Immunotherapy : CII·Yu Cheng TangAlbert Deisseroth
Feb 16, 2005·Apoptosis : an International Journal on Programmed Cell Death·S BouralexisA Evdokiou
Feb 11, 2005·Biotechnology Letters·Hang-Cheol Shin, Kwang-Hwi Cho
Mar 26, 1998·International Journal of Biological Macromolecules·G K PapadopoulosE Eliopoulos
Sep 6, 2002·Molecular Immunology·Janine L FerrantFrederick R Taylor
Jan 1, 2003·Journal of Neuroimmunology·Kakuri M Omari, Katerina Dorovini-Zis
Oct 29, 2002·Cellular Signalling·Ngan Lam, Bill Sugden
Oct 30, 1998·Cellular Signalling·J R Orlinick, M V Chao
Dec 15, 2000·Current Opinion in Structural Biology·E Y Jones
Feb 14, 2002·Trends in Biochemical Sciences·Jean-Luc BodmerJürg Tschopp
Jun 17, 2000·The International Journal of Biochemistry & Cell Biology·U SchönbeckP Libby
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·S M McWhirterT Alber
Oct 21, 2009·Current Opinion in Allergy and Clinical Immunology·Amy P HsuJulie E Niemela
Mar 3, 2006·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Jung-Sue ByunHyun-Soo Cho
May 30, 2009·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Thomas S WalterJingshan Ren
Aug 31, 2013·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·Vaheh OganesyanManuel Baca
Feb 26, 1998·Immunological Reviews·B ZhengG Kelsoe
Aug 13, 1998·Immunological Reviews·I D Campbell
Jan 15, 2014·Cytokine & Growth Factor Reviews·Pamela M Holland
Oct 2, 2003·Proceedings of the National Academy of Sciences of the United States of America·K S Srinivasa PrasadDavid R Phillips
Dec 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Lixin ZhangAlbert B Deisseroth
Jun 25, 2014·Seminars in Immunology·Matthew S Hayden, Sankar Ghosh
Nov 4, 2004·Biochemical and Biophysical Research Communications·Katsuya IwamotoToshio Suda
Aug 21, 2004·Pediatric Research·Amos Etzioni, Hans D Ochs
Dec 24, 2005·Nature Chemical Biology·Sylvie FournelGilles Guichard
Dec 24, 2005·Nature Chemical Biology·Sarah G Hymowitz, Avi Ashkenazi
Apr 11, 2006·Organic & Biomolecular Chemistry·Alberto BiancoGilles Guichard
May 2, 2003·Nature·Yingfang LiuGongyi Zhang
Apr 2, 2002·Journal of Immunotherapy·Paola CappelloMirella Giovarelli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.